Cargando…
Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program
BACKGROUND: Similar to many developed countries, vaccination against human papillomavirus (HPV) is provided only to girls in New Zealand and coverage is relatively low (47% in school-aged girls for dose 3). Some jurisdictions have already extended HPV vaccination to school-aged boys. Thus, explorati...
Autores principales: | Pearson, Amber L, Kvizhinadze, Giorgi, Wilson, Nick, Smith, Megan, Canfell, Karen, Blakely, Tony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082618/ https://www.ncbi.nlm.nih.gov/pubmed/24965837 http://dx.doi.org/10.1186/1471-2334-14-351 |
Ejemplares similares
-
Prevention of HPV-Related Cancers in Norway: Cost-Effectiveness of Expanding the HPV Vaccination Program to Include Pre-Adolescent Boys
por: Burger, Emily A., et al.
Publicado: (2014) -
Who Will Benefit From Expanding HPV Vaccination Programs to Boys?
por: Qendri, Venetia, et al.
Publicado: (2018) -
Hospitals, Schools, and Boys and Girls
Publicado: (1887) -
Boys and Girls in Secondary Schools
Publicado: (1923) -
Why equal treatment is not always equitable: the impact of existing ethnic health inequalities in cost-effectiveness modeling
por: McLeod, Melissa, et al.
Publicado: (2014)